Clinical Trials Directory

Trials / Terminated

TerminatedNCT01584752

Gore-BioA Fistula Plug to Treat Transsphincteric Fistulas

Clinical Multicenter Study of the Efficacy of Gore-BioA Fistula Plug in High Transsphincteric Perianal Fistulas

Status
Terminated
Phase
Study type
Observational
Enrollment
60 (actual)
Sponsor
Central Finland Hospital District · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This is a prospective clinical study on the efficacy of Gore-BioA fistula plug in high transsphincteric fistulas. Follow-up time is six months

Detailed description

Inclusion criteria for the study is a patient with ultrasound or MRI proven high transsphincteric perianal fistula. Patients with Crohns disease, immunosuppressive medication, anovaginal fistula, radiation therapy or chemotherapy are excluded. A Seton is placed in the fistula track for two months before the application of the plug. Patients are followed up for six months. Symptoms of fecal incontinence before and after intervention are monitored with the Cleveland clinic incontinence score.

Conditions

Interventions

TypeNameDescription
PROCEDUREGore-BioA Fistula PlugGore-BioA Fistula Plug

Timeline

Start date
2011-11-01
Primary completion
2014-12-01
Completion
2015-11-01
First posted
2012-04-25
Last updated
2019-07-26

Locations

7 sites across 1 country: Finland

Source: ClinicalTrials.gov record NCT01584752. Inclusion in this directory is not an endorsement.